Neopharm Labs

Neopharm Labs is a pharmaceutical industry player based in Canada, offering GMP analytical testing and R&D services to support the global community. Established in 1990, the company has demonstrated its commitment to growth and excellence through strategic acquisitions, including Averica Discovery (USA) and MS Pharma, and the launch of its Life Sciences Division. This expansion has positioned Neopharm as an integrated entity capable of effectively servicing partners within the pharmaceutical industry.

Neopharm emphasizes its dedication to meeting clients' analytical needs by delivering reliable, cost-effective, and innovative solutions. The company's team, comprised of experts with diverse scientific backgrounds and technical proficiencies, is adept at addressing complex challenges with precision and efficiency, aligning its success with that of its clients.

The company's mission is to collaborate with life sciences partners to assure product quality through proven analytical services. Furthermore, Neopharm aspires to become the benchmark for analytical services in the Canadian life sciences industry while upholding its status as an employer of choice and fostering a culture of excellence and innovation. Neopharm defines itself through its commitment to customer-centricity, quality, reliability, expertise, innovation, team spirit, rigor, commitment, and well-being and talent development.